病例339:肝细胞癌肾上腺转移灶对肝胆对比剂的摄取
66岁男性因轻度肝功能异常行腹部超声发现肝内大病灶,无肝硬化影像特征,进一步行肝脏MRI,随后行肿块切除及外科病理检查,术后4个月行 surveillance MRI。
要点
- 肝细胞癌肾上腺转移灶可对肝胆对比剂摄取,阅片时需注意识别。
- 无肝硬化背景的肝脏大病灶仍需警惕肝细胞癌可能。
- 术后4个月行 surveillance MRI 随访。
核心结论
- 肝细胞癌肾上腺转移灶对肝胆对比剂摄取,提示肝胆对比剂增强MRI上肾上腺转移灶可表现为摄取。
研究设计与样本
- 病例报告,1例66岁男性,行腹部超声、肝脏MRI、肿块切除及外科病理,术后4个月行 surveillance MRI。
关键影像表现/征象
- 腹部超声显示肝脏大病灶,其余肝脏正常,无肝硬化影像特征。
- MRI用于进一步表征肝脏病灶。
- 肝细胞癌肾上腺转移灶对肝胆对比剂摄取。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
A 66-year-old male patient with a background history of hypertension and no history of liver disease was found to have mildly deranged liver function test results as part of his annual hypertension review. Clinical examination findings were unremarkable, the patient was afebrile (36.8 °C), and other vital observations were within normal limits. Full blood count and urea and creatinine levels were within normal limits; however, liver function tests revealed a mildly elevated alanine aminotransferase level of 61 IU/L (1.02 μkat/L) (reference range, 0-40 IU/L [0-0.67 μkat/L]) and a mildly elevated γ-glutamyltransferase level of 52 IU/L (0.88 μkat/L) (reference range, 0-50 IU/L [0-0.83 μkat/L]). The patient subsequently underwent US examination of the abdomen, which revealed a large liver lesion in an otherwise normal liver with no imaging features of cirrhosis. MRI of the liver was performed for further characterization. The patient subsequently underwent resection of the large mass and surgical pathology. Surveillance MRI was performed 4 months after surgery.
引用
- Rea B, Blakeborough A. Case 339: Hepatobiliary Contrast Agent Uptake in an Adrenal Metastasis from Hepatocellular Carcinoma. Radiology. 2025. PMID: 40728406. doi:10.1148/radiol.242718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。